3,4-Bis(2-ethylhexyl)phthalic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3,4-Bis(2-ethylhexyl)phthalic acid
• 化学式: C₂₄H₃₈O₄
• 分子量: 390.6
• InChiKey: XZYRJVLKSRQAGD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.5
• 重原子数：
  28
• 可旋转键数：
  14
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Multitarget Compounds Active at a PPAR and Cannabinoid Receptor
  申请人：Desreumaux Pierre

  公开号：US20110039808A1

  公开（公告）日：2011-02-17

  There is a need for pharmaceutical compounds which have activity at, at least one of a PPAR and a cannabinoid receptor. Thus there are provided such compounds, wherein the compound comprises: a PPAR pharmacophore and a cannabinoid pharmacophore linked together by a moiety comprising a fused bicyclic ring comprising a five membered ring fused with a six membered ring or a six membered ring fused with a six membered ring; wherein the cannabinoid pharmacophore comprises the fused bicyclic ring; and the PPAR pharmacophore comprises a salicylic acid, alkoxybenzylacetic acid or a alkoxyphenylacetic acid functionality; and wherein the PPAR pharmacophore is linked to the bicyclic ring of the cannabinoid pharmacophore through a linker comprising an amine or an amide functional group.

  需要具有至少一种PPAR和大麻受体活性的药物化合物。因此提供了这样的化合物，其中该化合物包括：由包含一个五元环与一个六元环或一个六元环与一个六元环融合的融合双环环的基团连接在一起的PPAR药效团和大麻药效团；其中大麻药效团包括融合双环环；而PPAR药效团包括水杨酸、烷氧基苯乙酸或烷氧基苯乙酸官能团；PPAR药效团通过包含胺基或酰胺官能团的连接物连接到大麻药效团的双环环上。
• ASYMMETRIC ORGANIC PEROXIDE, CROSSLINKING AGENT COMPRISING THE SAME, AND METHOD OF CROSSLINKING WITH THE SAME
  申请人：NOF CORPORATION

  公开号：EP1233014A1

  公开（公告）日：2002-08-21

  A crosslinking agent comprising an asymmetry organic peroxide having at least one structure unit of (substituted)benzoylcarbonyloxy group represented by the following formula (1) in the molecule thereof. Environmentally friendly crosslinking agents and crosslinked silicone rubber moldings are provided thereby. Specifically, useful crosslinking agents and crosslinking processes for silicone rubber are provided.

  一种交联剂，包括至少具有分子中表示为以下式（1）的（取代）苯甲酰羰氧基结构单元的不对称有机过氧化物。因此提供了环保的交联剂和交联硅橡胶成型品。具体提供了用于硅橡胶的有用交联剂和交联工艺。
• Phosphorylated polymers and conjugates thereof
  申请人：Shalaby Wahba Shalaby

  公开号：US20060127354A1

  公开（公告）日：2006-06-15

  The present invention is directed to absorbable polyesters comprising one or more monophosphate functionality; a conjugate comprising the foregoing polyester and a peptide and/or a bioactive agent; microparticles comprising an absorbable polyester; a conjugate comprising the microparticles and a peptide and/or a bioactive agent; an acylated or alkylated polysaccharide having one or more monophosphate functionality; a conjugate comprising the acylated or alkylated polysaccharide and a peptide and/or a bioactive agent; and pharmaceutical compositions thereof.

  本发明涉及包含一种或多种单磷酸酯功能的可吸收聚酯；包括上述聚酯和肽和/或生物活性剂的共轭物；包含可吸收聚酯的微粒；包括微粒和肽和/或生物活性剂的共轭物；具有一种或多种单磷酸酯功能的酰化或烷基化多糖；包括酰化或烷基化多糖和肽和/或生物活性剂的共轭物；以及其制药组合物。
• Polyamines and their use as antibacterial and sensitizing agents
  申请人：David Sunil A.

  公开号：US20070197658A1

  公开（公告）日：2007-08-23

  Polyamines with varying chain-lengths were evaluated for antimicrobial activity in order to test the hypothesis that these bis-cationic amphipathic compounds may also bind to and permeabilize intact Gram negative bacterial membranes. The compounds were found to possess significant antimicrobial activity and mediated via permeabilization of bacterial membranes. Homologated spermine, bis-acylated with C 8 or C 9 chains was found to profoundly sensitize E. coli to hydrophobic antibiotics such as rifampicin.

  多种链长的多胺被评估其抗微生物活性，以验证这些双阳离子两性化合物可能也结合并使革兰氏阴性细菌膜通透的假设。发现这些化合物具有显著的抗微生物活性，并通过细菌膜通透介导。经过烷基化的精胺，与C8或C9链双酰化，被发现能显著增加大肠杆菌对亲脂性抗生素如利福平的敏感性。
• [EN] COMPOSITIONS OF IXABEPILONE<br/>[FR] COMPOSITIONS D'IXABÉPILONE
  申请人：R PHARM US OPERATING LLC

  公开号：WO2021142202A1

  公开（公告）日：2021-07-15

  Provided herein are compositions comprising ixabepilone, or a pharmaceutically acceptable salt thereof, and a copolymer represented by formula (I). Also provided are methods of treating cancer using the compositions described herein, and methods of preparing the compositions.

  本文提供了包含伊西贝匹隆或其药用盐以及由式(I)代表的共聚物的组合物。还提供了使用本文描述的组合物治疗癌症的方法，以及制备这些组合物的方法。